U.S. Electric Utilities Stock News

NasdaqGS:GNTX
NasdaqGS:GNTXAuto Components

Gentex (GNTX) Valuation Check After VOXX Acquisition Boosts Earnings And Multi Year Revenue Outlook

Why Gentex’s latest earnings and guidance matter for shareholders Gentex (GNTX) just reported first quarter results with higher sales, earnings per share, and profitability, raised its 2026 revenue outlook, and updated 2027 expectations, giving investors fresh information on the company’s current trajectory. See our latest analysis for Gentex. The stronger first quarter and higher 2026 and 2027 revenue guidance come against a backdrop where Gentex’s 1 month share price return of 9.53%...
NasdaqGS:HWKN
NasdaqGS:HWKNChemicals

Is It Too Late To Consider Hawkins (HWKN) After Its Strong Multi Year Share Price Run?

If you are wondering whether Hawkins at around US$166 per share still offers value or is running ahead of itself, you are not alone. The stock has recently logged returns of 1.4% over 7 days, 9.5% over 30 days, 14.3% year to date, 37.1% over 1 year, 322.5% over 3 years and 413.7% over 5 years, which naturally raises questions about what is already priced in. Recent coverage of Hawkins has focused on its long run share price performance and how it fits into broader materials sector themes,...
NYSE:BIPC
NYSE:BIPCGas Utilities

Brookfield Infrastructure Dividend Lift And Valuation Tension After Strong Quarter

Brookfield Infrastructure (NYSE:BIPC) reported strong first quarter results, pointing to solid operational performance across its portfolio. The company announced a 6% increase in its quarterly distribution, signaling management's confidence in the business outlook. Management highlighted progress on new partnerships and organic growth initiatives alongside the distribution change. Brookfield Infrastructure, through NYSE:BIPC, focuses on essential assets such as utilities, transport,...
NasdaqGS:LSTR
NasdaqGS:LSTRTransportation

Is It Too Late To Consider Landstar System (LSTR) After Its Strong 1 Year Rally?

If you are wondering whether Landstar System at US$182.41 is offering value right now, the next sections will walk through what the current share price might be implying. The stock has returned 2.8% over the last 7 days, 16.2% over 30 days, 24.3% year to date, 39.5% over 1 year, 7.8% over 3 years, and 13.6% over 5 years, which gives useful context before looking at what the valuation suggests today. Recent coverage has focused on Landstar System as a key player in the US transportation and...
NYSE:TRU
NYSE:TRUProfessional Services

Is TransUnion (TRU) Now Attractive After Recent Share Price Weakness?

Wondering whether TransUnion at around US$70 a share looks cheap, expensive, or somewhere in between? This article walks through the numbers so you can judge the price tag with more confidence. The stock is down about 9.5% over the last week and 15.9% year to date, while the 3 year return sits at 7.1%. These mixed figures can leave you questioning whether recent moves point to improving prospects or rising concerns. Recent headlines have focused on TransUnion as one of the major credit data...
NYSE:LAW
NYSE:LAWSoftware

The Bull Case For CS Disco (LAW) Could Change Following Appointment Of AI SaaS Leader Toby Williams

CS Disco recently appointed Toby Williams, the AI SaaS veteran and current President and CEO of Paylocity, to its Board of Directors, effective April 22, 2026, adding deep experience in cloud-based software, corporate finance, and product strategy. Williams’ blend of legal training, investment banking, and executive leadership in scaled SaaS platforms may influence how CS Disco shapes its AI-powered legal technology roadmap and longer-term business priorities. We'll now examine how adding AI...
NYSE:QTWO
NYSE:QTWOSoftware

High Growth Tech Stocks To Watch In The US April 2026

Over the last 7 days, the United States market has remained flat, although it is up 29% over the past year with earnings forecast to grow by 16% annually. In this context of steady growth, identifying high-growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these positive market conditions.
NasdaqGS:PTRN
NasdaqGS:PTRNMultiline Retail

3 Stocks Estimated To Be Trading Below Intrinsic Value By Up To 35.4%

The United States market has remained flat over the last week but has seen a significant rise of 29% over the past 12 months, with earnings forecasted to grow by 16% annually. In this context, identifying stocks that are trading below their intrinsic value can present compelling opportunities for investors seeking to capitalize on potential growth while navigating current market conditions.
NasdaqGM:AGNT
NasdaqGM:AGNTReal Estate

Is It Time To Reconsider eXp World Holdings (EXPI) After Prolonged Share Price Weakness

If you are wondering whether eXp World Holdings at around US$6.56 is priced for a comeback or still carries too much risk, the first step is understanding what the current market value actually reflects. The stock has returned 1.1% over the last 7 days and 9.5% over the last 30 days, yet year to date it is down 27.9% and the 1 year return is a 25.1% decline, with 3 and 5 year returns of 39.4% and 77.6% declines respectively. Recent coverage has focused on eXp World Holdings as part of...
NasdaqCM:MBIN
NasdaqCM:MBINDiversified Financial

Insider Owned Growth Companies To Watch In April 2026

The United States market has remained flat over the last week but has experienced a significant 29% increase over the past year, with earnings forecasted to grow by 16% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they may indicate strong confidence in the company's future prospects from those who know it best.
NYSE:AUB
NYSE:AUBBanks

Is Atlantic Union Bankshares (AUB) Offering Value After Strong One Year Share Price Performance

Wondering whether Atlantic Union Bankshares at around US$38.10 is offering fair value or a potential mispricing opportunity for your portfolio right now. The stock has posted returns of 1.4% over the last 7 days, 9.5% over 30 days, 7.3% year to date, 42.9% over 1 year and 67.4% over 3 years, with a 5 year return of 15.4%. This naturally puts a spotlight on what you might be paying for that performance today. These moves sit against a backdrop of ongoing news flow around U.S. regional banks,...
NasdaqGS:KLTR
NasdaqGS:KLTRSoftware

Kaltura (KLTR) Valuation Check After New AI Products Partnerships And Infrastructure Expansion

Kaltura (KLTR) has packed the past few weeks with AI-focused product launches, regional infrastructure expansion, and high profile partnerships, putting its agentic digital experience strategy squarely in focus for current and prospective shareholders. See our latest analysis for Kaltura. Despite a busy April calendar of AI product releases, infrastructure rollouts, and conference appearances, Kaltura’s recent 30 day share price return of 18.40% follows a 90 day share price return decline of...
NYSE:PSA
NYSE:PSASpecialized REITs

Public Storage (PSA) FFO Near US$773m Tests Bullish Margin Resilience Narrative

Public Storage (PSA) opened 2026 with Q1 revenue of US$1.2 billion, basic EPS of US$2.72, and funds from operations of US$772.7 million, setting a clear marker for how the storage REIT is entering the new year. Over the past five quarters, revenue has moved from US$1.19 billion in Q1 2025 to US$1.22 billion in Q1 2026, while basic EPS shifted from US$2.04 to US$2.72 over the same span. This gives investors a clear view of how the top line and per share results have tracked through recent...
NasdaqGM:FOLD
NasdaqGM:FOLDBiotechs

BioMarin Closes Amicus Deal As FOLD Delists And Indices Adjust

BioMarin Pharmaceutical has completed its acquisition of Amicus Therapeutics, previously listed as NasdaqGM:FOLD. Following the transaction, Amicus has been delisted from the Nasdaq and removed from major indices including the S&P and Russell families. The deal ends Amicus's status as an independent public company and sets up integration of its rare disease portfolio into BioMarin. For investors who followed Amicus Therapeutics at a share price of $14.49 and a value score of 3, the...
NYSE:TAL
NYSE:TALConsumer Services

Is It Time To Revisit TAL Education Group (TAL) After Regulatory Shifts And Price Swings

If you are wondering whether TAL Education Group at around US$10.77 is priced attractively or not, the key question is whether the current share price lines up with the underlying value of the business. The stock has seen mixed returns, with a 9.9% decline over the last 7 days, a 0.5% decline over 30 days, a 6.3% decline year to date, an 18.6% gain over the past year and a 104.8% gain over three years, set against an 80.8% loss over five years. Recent share price moves sit against a backdrop...
NasdaqGM:ACMR
NasdaqGM:ACMRSemiconductor

ACM Research’s New PECVD System Tests Valuation And Momentum Story

ACM Research shipped the world's first three-station rotating PECVD SiCN system, introducing a new architecture for advanced semiconductor manufacturing. The system is designed to improve film stability and process control for advanced back-end-of-line and packaging applications. This shipment marks a fresh addition to ACM Research's product lineup that has not been covered in recent company news. ACM Research (NasdaqGM:ACMR) is drawing attention with this new PECVD SiCN tool at a time when...
NasdaqGS:PTCT
NasdaqGS:PTCTBiotechs

Is PTC Therapeutics (PTCT) Pricing Reflect Recent Pipeline Progress And Volatile Share Performance

If you are wondering whether PTC Therapeutics at around US$70.26 is offering fair value or hidden upside, the starting point is to understand what the current market price is actually baking in. The stock has been volatile, with a 0.5% decline over the last 7 days, a 6.2% gain over the last 30 days, an 8.4% decline year to date, and a 41.9% return over the past year that sits alongside multi year returns of 27.8% over 3 years and 82.6% over 5 years. Behind these moves, investors have been...
NasdaqCM:CMPX
NasdaqCM:CMPXBiotechs

Compass Therapeutics (CMPX) Is Down 65.4% After Tovecimig Combo Meets Key BTC Trial Endpoints - What's Changed

In April 2026, Compass Therapeutics reported that its Phase 2/3 COMPANION-002 trial in advanced biliary tract cancer met the primary endpoint of overall response rate and a key secondary endpoint of progression-free survival for tovecimig plus paclitaxel versus paclitaxel alone, with no new safety concerns observed. An intriguing finding was that patients who crossed over from paclitaxel alone to the tovecimig combination lived longer than those who stayed on paclitaxel, despite initially...
NYSE:TNET
NYSE:TNETProfessional Services

TriNet Shelf Registration Adds Funding Flexibility To Undervalued Stock Story

TriNet Group (NYSE:TNET) has filed an omnibus or universal shelf registration statement. The filing allows the company to issue common and preferred stock, debt securities, warrants, depositary shares, purchase contracts, and units. The shelf registration can be used over time for fundraising, capital structure changes, or acquisition related financing. TriNet Group (NYSE:TNET) provides human resources solutions for small and medium sized businesses, so access to flexible funding tools can...
NYSE:AWI
NYSE:AWIBuilding

Is Armstrong World Industries (AWI) Offering Value After Recent Share Price Volatility?

If you are wondering whether Armstrong World Industries at around US$169.84 is offering fair value right now, you are not alone. That is exactly what this article will unpack for you. The stock has seen a 4.4% decline over the last 7 days, a 4.7% gain over the past month, a 13.7% decline year to date, and a 17.7% return over the last year, which can change how investors think about both its potential and its risks. That mixed performance sits against a backdrop of ongoing interest in...
NYSE:APLE
NYSE:APLEHotel and Resort REITs

Is It Time To Revisit Apple Hospitality REIT (APLE) After Its Strong 1-Year Rally?

If you are looking at Apple Hospitality REIT and wondering whether the current price really reflects its value, you are not alone. The stock last closed at US$13.39, with returns of 3.0% over 7 days, 16.5% over 30 days, 11.0% year to date, and 22.5% over 1 year, which will naturally have valuation on many investors' minds. Recent attention on the company has focused on how its portfolio of hotel assets trades relative to other listed real estate investment trusts, and whether current...
NasdaqGS:WASH
NasdaqGS:WASHBanks

3 Undervalued Small Caps With Insider Buying Across Global Markets

Over the last 7 days, the United States market has remained flat, yet it is up 29% over the past year with earnings expected to grow by 16% per annum in the coming years. In this environment, identifying stocks that are perceived as undervalued can be particularly appealing, especially when there is insider buying activity signaling potential confidence from those within the company.